NCT00004051 |
|
Irinotecan in Treating Patients With Advanced Solid Tumors
|
View
|
NCT00004050 |
|
Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
|
View
|
NCT00004049 |
|
SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors
|
View
|
NCT00004048 |
|
Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
|
View
|
NCT00004047 |
|
Chemotherapy in Treating Patients Who Have Hematologic Cancer
|
View
|
NCT00004046 |
|
Chemotherapy in Treating Women With Metastatic Breast Cancer
|
View
|
NCT00004045 |
|
Chemotherapy in Treating Patients With Prostate Cancer
|
View
|
NCT00004043 |
|
Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
|
View
|
NCT00004042 |
|
Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer
|
View
|
NCT00004041 |
|
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
|
View
|
NCT00004040 |
|
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
|
View
|
NCT00004039 |
|
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
|
View
|
NCT00004038 |
|
Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
|
View
|
NCT00004037 |
|
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
|
View
|
NCT00004036 |
|
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
|
View
|
NCT00004033 |
|
Liposomal-Cisplatin Analogue L-NDDP in Treating Patients With Malignant Pleural Mesothelioma
|
View
|
NCT00004032 |
|
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
|
View
|
NCT00004031 |
|
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkins Lymphoma
|
View
|
NCT00004030 |
|
VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
|
View
|
NCT00004029 |
|
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
|
View
|
NCT00004028 |
|
Carmustine in Treating Patients With Recurrent Malignant Glioma
|
View
|
NCT00004026 |
|
CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
|
View
|
NCT00004025 |
|
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
|
View
|
NCT00004024 |
|
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
|
View
|
NCT00004022 |
|
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
|
View
|
NCT00004017 |
|
Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
|
View
|
NCT00004016 |
|
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
|
View
|
NCT00004015 |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
|
View
|
NCT00004014 |
|
Liposomal Doxorubicin in Treating Patients With Prostate Cancer
|
View
|
NCT00004013 |
|
Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer
|
View
|
NCT00004012 |
|
Capecitabine in Treating Patients With Recurrent Ovarian Fallopian Tube or Primary Peritoneal Cancer
|
View
|
NCT00004011 |
|
S9900 Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
|
View
|
NCT00004010 |
|
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II Stage III or Stage IV Hodgkins Disease
|
View
|
NCT00004009 |
|
R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
|
View
|
NCT00004008 |
|
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
|
View
|
NCT00004006 |
|
Combination Chemotherapy Radiation Therapy and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
|
View
|
NCT00004005 |
|
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma Cancer Other Refractory Carcinoma or Metastatic Adenoma Cancer of Unknown Primary Origin
|
View
|
NCT00004004 |
|
Procarbazine in Treating Patients With Recurrent Brain Tumor
|
View
|
NCT00004003 |
|
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
|
View
|
NCT00004002 |
|
PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
|
View
|
NCT00004001 |
|
S9916 Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
|
View
|
NCT00003998 |
|
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
|
View
|
NCT00003997 |
|
6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome Acute Myeloid Leukemia Acute Lymphocytic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
|
View
|
NCT00003996 |
|
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
View
|
NCT00003995 |
|
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
|
View
|
NCT00003994 |
|
Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
|
View
|
NCT00003993 |
|
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
|
View
|
NCT00003992 |
|
Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
|
View
|
NCT00003991 |
|
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
|
View
|
NCT00003989 |
|
ISIS 3521 in Treating Patients With Advanced Unresectable or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
|
View
|
NCT00003985 |
|
KRN7000 in Treating Patients With Solid Tumors
|
View
|
NCT00003984 |
|
Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
|
View
|
NCT00003982 |
|
MEN-10755 in Treating Patients With Solid Tumors
|
View
|
NCT00003981 |
|
E7070 in Treating Patients With Solid Tumors
|
View
|
NCT00003980 |
|
BIBX 1382 in Treating Patients With Solid Tumors
|
View
|
NCT00003979 |
|
CHS 828 in Treating Patients With Solid Tumors
|
View
|
NCT00003977 |
|
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
|
View
|
NCT00003976 |
|
E7070 in Treating Patients With Solid Tumors
|
View
|
NCT00003974 |
|
Vaccine Therapy in Treating Patients With Stage I Stage II or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
|
View
|
NCT00003972 |
|
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
|
View
|
NCT00003970 |
|
Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
|
View
|
NCT00003969 |
|
Geldanamycin Analogue in Treating Patients With Advanced Cancer
|
View
|
NCT00003968 |
|
Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
|
View
|
NCT00003967 |
|
Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian Peritoneal or Fallopian Tube Cancer
|
View
|
NCT00003966 |
|
Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
|
View
|
NCT00003963 |
|
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkins Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
|
View
|
NCT00003962 |
|
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
|
View
|
NCT00003961 |
|
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
|
View
|
NCT00003960 |
|
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
|
View
|
NCT00003959 |
|
Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
|
View
|
NCT00003958 |
|
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
|
View
|
NCT00003957 |
|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkins Lymphoma
|
View
|
NCT00003956 |
|
Combination Chemotherapy in Treating Patients With Advanced Cancer
|
View
|
NCT00003955 |
|
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
|
View
|
NCT00003954 |
|
Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
|
View
|
NCT00003953 |
|
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
|
View
|
NCT00003951 |
|
DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
|
View
|
NCT00003950 |
|
Irinotecan and Cyclosporine in Treating Patients With Metastatic Advanced or Locally Recurrent Colorectal Cancer
|
View
|
NCT00003946 |
|
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
|
View
|
NCT00003945 |
|
Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer
|
View
|
NCT00003944 |
|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Fallopian Tube or Primary Peritoneal Cancer
|
View
|
NCT00003943 |
|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer
|
View
|
NCT00003942 |
|
Gene Therapy Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkins Lymphoma
|
View
|
NCT00003941 |
|
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
|
View
|
NCT00003939 |
|
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
|
View
|
NCT00003938 |
|
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
|
View
|
NCT00003937 |
|
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
|
View
|
NCT00003936 |
|
Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkins Disease
|
View
|
NCT00003935 |
|
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
|
View
|
NCT00003934 |
|
Tretinoin Cytarabine and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
|
View
|
NCT00003933 |
|
Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
|
View
|
NCT00003931 |
|
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
|
View
|
NCT00003930 |
|
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
|
View
|
NCT00003929 |
|
Chemotherapy Filgrastim and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
|
View
|
NCT00003928 |
|
Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
|
View
|
NCT00003927 |
|
Combination Chemotherapy Amifostine and Peripheral Stem Cell Transplantation in Treating Patients With Stage II Stage III or Stage IV Breast Cancer
|
View
|
NCT00003926 |
|
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
|
View
|
NCT00003925 |
|
Combination Chemotherapy In Treating Patients With Advanced Cancer
|
View
|
NCT00003924 |
|
Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkins Disease or Non-Hodgkins Lymphoma
|
View
|
NCT00003923 |
|
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct Gallbladder or Pancreas
|
View
|
NCT00003920 |
|
Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
|
View
|
NCT00003917 |
|
Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
|
View
|
NCT00003916 |
|
Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma
|
View
|
NCT00003914 |
|
Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
|
View
|
NCT00003913 |
|
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
|
View
|
NCT00003912 |
|
Chemotherapy in Treating Children With Liver Cancer
|
View
|
NCT00003911 |
|
S9903 Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
|
View
|
NCT00003910 |
|
Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
|
View
|
NCT00003909 |
|
Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
|
View
|
NCT00003908 |
|
S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
|
View
|
NCT00003907 |
|
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
|
View
|
NCT00003906 |
|
Study of Tamoxifen and Raloxifene STAR for the Prevention of Breast Cancer in Postmenopausal Women
|
View
|
NCT00003903 |
|
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
|
View
|
NCT00003902 |
|
Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
|
View
|
NCT00003901 |
|
Prognostic Study of Metastases in Patients With Stage I Stage II or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
|
View
|
NCT00003900 |
|
Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer
|
View
|
NCT00003899 |
|
Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
|
View
|
NCT00003898 |
|
Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
|
View
|
NCT00003897 |
|
Vaccine Therapy With gp100 andor Sargramostim in Treating Patients With Malignant Melanoma
|
View
|
NCT00003896 |
|
S9912 Combination Chemo in Stage III Ovarian Cancer
|
View
|
NCT00003895 |
|
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
|
View
|
NCT00003894 |
|
Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant
|
View
|
NCT00003893 |
|
Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
|
View
|
NCT00003892 |
|
ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
|
View
|
NCT00003891 |
|
Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
|
View
|
NCT00003890 |
|
MG98 in Treating Patients With Advanced Solid Tumors
|
View
|
NCT00003888 |
|
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
|
View
|
NCT00003887 |
|
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
|
View
|
NCT00003885 |
|
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia Chronic Myeloide Leukemia Myelodysplasia Lymphoma or Myeloma
|
View
|
NCT00003884 |
|
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
|
View
|
NCT00003883 |
|
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
|
View
|
NCT00003882 |
|
Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors
|
View
|
NCT00003881 |
|
Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
|
View
|
NCT00003880 |
|
Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
|
View
|
NCT00003878 |
|
Carmustine Implants in Treating Patients With Brain Metastases
|
View
|
NCT00003877 |
|
Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
|
View
|
NCT00003876 |
|
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
|
View
|
NCT00003875 |
|
Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
|
View
|
NCT00003874 |
|
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
|
View
|
NCT00003873 |
|
Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
|
View
|
NCT00003871 |
|
PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
|
View
|
NCT00003870 |
|
Monoclonal Antibody Therapy Cyclophosphamide and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
|
View
|
NCT00003869 |
|
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
|
View
|
NCT00003868 |
|
Radiolabeled Monoclonal Antibody Cyclophosphamide and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
|
View
|
NCT00003867 |
|
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
|
View
|
NCT00003865 |
|
Toremifene in Treating Patients With Ovarian Cancer
|
View
|
NCT00003864 |
|
Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
|
View
|
NCT00003863 |
|
Diagnostic Study of Patients With Aggressive Non-Hodgkins Lymphoma
|
View
|
NCT00003862 |
|
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
|
View
|
NCT00003861 |
|
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
|
View
|
NCT00003860 |
|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
|
View
|
NCT00003859 |
|
Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS
|
View
|
NCT00003858 |
|
Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
|
View
|
NCT00003857 |
|
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
|
View
|
NCT00003856 |
|
Photodynamic Therapy in Treating Patients With Recurrent Refractory or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
|
View
|
NCT00003855 |
|
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
|
View
|
NCT00003854 |
|
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
|
View
|
NCT00003853 |
|
4-Iodo-4-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
|
View
|
NCT00003852 |
|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
|
View
|
NCT00003851 |
|
Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet Gonzalez Regimen in Treating Patients Who Have Stage II Stage III or Stage IV Pancreatic Cancer
|
View
|
NCT00003850 |
|
Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
|
View
|
NCT00003849 |
|
Rituximab in Treating Patients With Non-Hodgkins Lymphoma or Hodgkins Disease
|
View
|
NCT00003847 |
|
VX-710 Doxorubicin and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer
|
View
|
NCT00003846 |
|
Radiation Therapy Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors
|
View
|
NCT00003843 |
|
Irinotecan in Treating Patients With Colorectal Cancer
|
View
|
NCT00003842 |
|
IL-438-37-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
|
View
|
NCT00003840 |
|
DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
|
View
|
NCT00003838 |
|
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
|
View
|
NCT00003837 |
|
506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
|
View
|
NCT00003835 |
|
Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
|
View
|
NCT00003834 |
|
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
|
View
|
NCT00003833 |
|
Genetic Study in Patients With Stage II or Stage III Colon Cancer
|
View
|
NCT00003832 |
|
Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
|
View
|
NCT00003831 |
|
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
|
View
|
NCT00003830 |
|
Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
|
View
|
NCT00003829 |
|
Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
|
View
|
NCT00003828 |
|
S9804 Vinorelbine in Treating Patients With Stage IV Melanoma
|
View
|
NCT00003827 |
|
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
|
View
|
NCT00003825 |
|
Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
|
View
|
NCT00003824 |
|
S9809 Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
|
View
|
NCT00003822 |
|
SR-45023A in Treating Patients With Advanced Solid Tumors
|
View
|
NCT00003821 |
|
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
|
View
|
NCT00003820 |
|
Rituximab in Treating Patients With Hodgkins Lymphoma
|
View
|
NCT00003819 |
|
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
|
View
|
NCT00003817 |
|
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
|
View
|
NCT00003816 |
|
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
|
View
|
NCT00003815 |
|
Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkins Lymphoma
|
View
|
NCT00003814 |
|
Eflornithine in Treating Patients With Bladder Cancer
|
View
|
NCT00003812 |
|
Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
|
View
|
NCT00003811 |
|
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
|
View
|
NCT00003810 |
|
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
|
View
|
NCT00003809 |
|
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
|
View
|
NCT00003808 |
|
Theophylline in Treating Patients With In Situ Stage I or Stage II Chronic Lymphocytic Leukemia
|
View
|
NCT00003805 |
|
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
|
View
|
NCT00003804 |
|
Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms Tumor
|
View
|
NCT00003803 |
|
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
|
View
|
NCT00003802 |
|
Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
|
View
|
NCT00003801 |
|
Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
|
View
|
NCT00003800 |
|
Diagnostic Study of Patients With Stage I Testicular Cancer
|
View
|
NCT00003799 |
|
Chemotherapy Radiation Therapy and Surgery in Treating Patients With Locally Advanced Rectal Cancer
|
View
|